Details
The application of genomics technology for analysis of liquid biopsy samples is rapidly growing. In particular, cell-free DNA (cfDNA) is the analyte that has the potential to reveal detailed information on disease progression.
Tune in to our 3-part video series
- Multiomic analysis of liquid biopsy samples
Anna Babayan, Illumina
- Cell-free DNA Prep with Enrichment library prep kit
Mariela Cuadras, Illumina
- Whole exome sequencing of cfDNA in metastatic prostate cancer – customer presentation
Tina Moser, MedUni Graz
Complete the form to access the video recordings
Your email address is never shared with third parties.
- Date & Time
- 16 Apr 2024
- Topic
- Cancer research